These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Medicinal chemistry of adenosine, P2Y and P2X receptors. Jacobson KA; Müller CE Neuropharmacology; 2016 May; 104():31-49. PubMed ID: 26686393 [TBL] [Abstract][Full Text] [Related]
3. Functionalized congener approach to the design of ligands for G protein-coupled receptors (GPCRs). Jacobson KA Bioconjug Chem; 2009 Oct; 20(10):1816-35. PubMed ID: 19405524 [TBL] [Abstract][Full Text] [Related]
4. Structure-based approaches to ligands for G-protein-coupled adenosine and P2Y receptors, from small molecules to nanoconjugates. Jacobson KA J Med Chem; 2013 May; 56(10):3749-67. PubMed ID: 23597047 [TBL] [Abstract][Full Text] [Related]
5. GPR17: molecular modeling and dynamics studies of the 3-D structure and purinergic ligand binding features in comparison with P2Y receptors. Parravicini C; Ranghino G; Abbracchio MP; Fantucci P BMC Bioinformatics; 2008 Jun; 9():263. PubMed ID: 18533035 [TBL] [Abstract][Full Text] [Related]
6. Mining human genome for novel purinergic P2Y receptors: a sequence analysis and molecular modeling approach. Bhatnagar S; Mishra S; Pathak R J Recept Signal Transduct Res; 2011 Feb; 31(1):75-84. PubMed ID: 21142848 [TBL] [Abstract][Full Text] [Related]
7. Pharmacology and structure of P2Y receptors. von Kügelgen I; Hoffmann K Neuropharmacology; 2016 May; 104():50-61. PubMed ID: 26519900 [TBL] [Abstract][Full Text] [Related]
9. Structural probing of off-target G protein-coupled receptor activities within a series of adenosine/adenine congeners. Paoletta S; Tosh DK; Salvemini D; Jacobson KA PLoS One; 2014; 9(5):e97858. PubMed ID: 24859150 [TBL] [Abstract][Full Text] [Related]
13. New insights for drug design from the X-ray crystallographic structures of G-protein-coupled receptors. Jacobson KA; Costanzi S Mol Pharmacol; 2012 Sep; 82(3):361-71. PubMed ID: 22695719 [TBL] [Abstract][Full Text] [Related]
14. In Silico Drug Design for Purinergic GPCRs: Overview on Molecular Dynamics Applied to Adenosine and P2Y Receptors. Salmaso V; Jacobson KA Biomolecules; 2020 May; 10(6):. PubMed ID: 32466404 [TBL] [Abstract][Full Text] [Related]
15. Architecture of P2Y nucleotide receptors: structural comparison based on sequence analysis, mutagenesis, and homology modeling. Costanzi S; Mamedova L; Gao ZG; Jacobson KA J Med Chem; 2004 Oct; 47(22):5393-404. PubMed ID: 15481977 [TBL] [Abstract][Full Text] [Related]
16. Ligand-based homology modeling as attractive tool to inspect GPCR structural plasticity. Moro S; Deflorian F; Bacilieri M; Spalluto G Curr Pharm Des; 2006; 12(17):2175-85. PubMed ID: 16796562 [TBL] [Abstract][Full Text] [Related]
17. Pharmacology of P2Y receptors. von Kügelgen I Brain Res Bull; 2019 Sep; 151():12-24. PubMed ID: 30922852 [TBL] [Abstract][Full Text] [Related]
18. Breakthrough in GPCR Crystallography and Its Impact on Computer-Aided Drug Design. Ciancetta A; Jacobson KA Methods Mol Biol; 2018; 1705():45-72. PubMed ID: 29188558 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of homology modeling of G-protein-coupled receptors in light of the A(2A) adenosine receptor crystallographic structure. Ivanov AA; Barak D; Jacobson KA J Med Chem; 2009 May; 52(10):3284-92. PubMed ID: 19402631 [TBL] [Abstract][Full Text] [Related]
20. Integrating Pharmacophore into Membrane Molecular Dynamics Simulations to Improve Homology Modeling of G Protein-coupled Receptors with Ligand Selectivity: A2A Adenosine Receptor as an Example. Zeng L; Guan M; Jin H; Liu Z; Zhang L Chem Biol Drug Des; 2015 Dec; 86(6):1438-50. PubMed ID: 26072970 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]